Proteomics

Dataset Information

32

Characterisation of the Beta-Catenin cytoplasmic/nuclear interactome in leukaemia cells


ABSTRACT: Canonical Wnt/B-catenin signaling is frequently dysregulated in myeloid leukemias and is implicated in leukemogenesis. Nuclear-localized β-catenin is indicative of active Wnt signaling and is frequently observed in acute myeloid leukemia (AML) patients; however, some patients exhibit little or no β-catenin nuclear-localization even where cytosolic B-catenin is abundant. Differential propensity for nuclear-localized β-catenin is also observed in cell lines. To investigate the factors mediating the nuclear-localization of B-catenin we carried out a nuclear/cytoplasmic proteomic analysis of the B-catenin interactome in myeloid leukemia cells. From this we identified hundreds of putative novel B-catenin-interactors. Comparison of interacting factors between Wnt-responsive cells (high nuclear B-catenin, K562/HEL) versus Wnt-unresponsive cells (low nuclear B-catenin, ML1) suggested the established interactor, LEF1, is a key factor mediating the nuclear-localization of B-catenin in myeloid leukemia. The relative levels of nuclear LEF1 and B-catenin were tightly correlated in both cell lines and in primary AML blasts. Furthermore, LEF1 knockdown inhibited B-catenin nuclear-localization and transcriptional activation in Wnt-responsive cells. Conversely, LEF1 overexpression was able to promote both nuclear-localization and B-catenin-dependent transcriptional responses in previously Wnt-unresponsive cells. This study is the first to present a B-catenin interactome in hematopoietic cells and reveals LEF1 as a critical regulator of canonical Wnt signaling in myeloid leukemia.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Homo sapiens  

TISSUE(S): Myelocytic Leukemia Cell Line

DISEASE(S): Acute Myeloid Leukemia,Chronic Myeloid Leukemia

SUBMITTER: Rhys Morgan  

LAB HEAD: Rhys Gareth Morgan

PROVIDER: PXD009305 | Pride | 2019-01-11

REPOSITORIES: Pride

altmetric image

Publications


Canonical Wnt/β-catenin signaling is frequently dysregulated in myeloid leukemias and is implicated in leukemogenesis. Nuclear-localized β-catenin is indicative of active Wnt signaling and is frequently observed in acute myeloid leukemia (AML) patients; however, some patients exhibit little or no nuclear β-catenin even where cytosolic β-catenin is abundant. Control of the subcellular localization of β-catenin therefore represents an additional mechanism regulating Wnt signaling in hematopoietic  ...[more]

Similar Datasets

2010-04-20 | E-GEOD-21367 | ArrayExpress
2014-02-13 | E-GEOD-51402 | ArrayExpress
| GSE51402 | GEO
2018-11-22 | E-MTAB-7028 | ArrayExpress
2019-03-29 | PXD013095 | Pride
2014-03-12 | E-GEOD-53927 | ArrayExpress
2018-10-25 | PXD010421 | Pride
2013-07-26 | E-GEOD-49199 | ArrayExpress
2014-02-08 | E-GEOD-54793 | ArrayExpress
2016-09-01 | E-GEOD-78125 | ArrayExpress